secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001493152-23-021231
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience Q3 net product sales down 18% YoY to $406K; net loss widens to $876K
--------------------------------------------------------------------------------

- Net product sales $406K in Q3 FY2023 vs $497K prior year, down 18% on decreased distribution sales.
- Q3 net loss $876K vs $760K prior year; net loss per share flat at ($0.01).
- Nine-month net product sales $1.27M vs $1.41M; net loss $2.93M vs $2.26M prior year.
- CEO cites key distributor downturn; food division sales partially offset; new sales program initiated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223021231/0001493152-23-021231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223021231/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer